Clinical Trial Update: Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial combining stereotactic body radiation therapy with T-cell infusion for metastatic renal cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Stereotactic Body Radiation Therapy (SBRT)
• T-cell infusion

Snippet

Sponsor: Stanford University | Conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 1 | Status: TERMINATED